Clinical Trial Update: Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction and maintenance with ofatumumab in elderly patients with poor-risk chronic lymphocytic leukemia undergoing allogeneic transpl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Chronic Lymphatic Leukemia | Phase 2 | Status: COMPLETED